L. Roy Papp & Associates, LLP - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 43 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is 5.21 and the average weighting 0.2%.

Links
Filings
Quarter-by-quarter ownership
L. Roy Papp & Associates, LLP ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q1 2020$15,000
-40.0%
26,000
+36.8%
0.00%
-25.0%
Q4 2019$25,000
-34.2%
19,0000.0%0.00%
-33.3%
Q3 2019$38,000
-17.4%
19,0000.0%0.01%
-14.3%
Q2 2019$46,000–19,000–0.01%–
 Download
Other shareholders

There were no reported owners of NABRIVA THERAPEUTICS PLC in Q2 2019.

NameSharesValueWeighting ↓
View complete list of NABRIVA THERAPEUTICS PLC shareholders